Skip to main content
RVRC logo

RVRC · Revium Rx.

Track RVRC — free
$1.43 At close · Sep 7
Market Cap
$86.84M
Shares
60.73M
Volume · Sep 7 248 Avg daily vol (2 sessions) 248

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$1.43 Open$1.43 Day$1.43–1.43 Available close range$1.43–1.67 Avg vol 30d308 Short vol100% DataJan 2020–Sep 2026 Filing10-Q · Aug 13

The closing range uses available history since Jan 5, 2026; less than a full year is stored.

Up next

filed Aug 13, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
−$13.25M
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
$842,000
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+0.0%
Year over year
Price change (1Y)
—
Trailing year
Short interest
—
Latest settlement
View all 122 metrics

Equibles Rating

blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical Sell Momentum Very Strong Sentiment Neutral Fundamentals Limited Quant / Vol Very High
Market backdrop VIX 16.7 · calm Equity put/call 0.52
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 50-day avg −57%
below
RSI (14) 47
neutral
MACD trend Positive
52-week position 0%
near low
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Strong
1-month return +6%
trailing
YTD return +175%
this year
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50/200-day averages unavailable
Institutional flow Flat
No 13F holder data
Insider flow Flat
No net insider activity over 90 days
Short interest Flat
No short-interest data
Volume signal Normal
Volume near normal
Institution breadth Steady
No 13F holder history
Fundamentals
Limited
Not enough data for a confident read.
Quant / Vol
risk profile
Very High
Volatility 841%
annualized · 1-yr
Max drawdown −98%
past year
ATR 58.0%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Sell
2 · 3 · 1
50 / 200-day cross
No cross Neutral
Price vs 50-day avg
−57% Bearish
RSI (14)
47 Neutral
MACD trend
Positive Bullish
52-week position
0% Bearish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
No clear signal
Trend (MA cross) No cross
50/200-day averages unavailable
Institutional flow Flat
No 13F holder data
Insider flow Flat
No net insider activity over 90 days
Short interest Flat
No short-interest data
Volume signal Normal
Volume near normal
Institution breadth Steady
No 13F holder history
Price context
position in its available closing range
Range low $1 Now $1 · 0% Range high $2
vs 50-day avg -57%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

KPI extraction has been attempted, but no publishable series is available from the examined filings. This is not evidence that the company reports no KPIs.

Versus peers

Health Information Services — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
RVRC
Revium Rx.
this stock
$86.84M — — — —
VEEV
Veeva Systems Inc
$51.80B +43.6% +28.1% 52.4 3.0%
PMDIY
Pro Medicus Ltd.
$12.77B -26.4% — — 0.0%
BTSG
BrightSpring Health Services, Inc.
$12.34B +66.5% +28.2% 37.8 6.1%
TEM
Tempus AI, Inc.
$12.01B +14.8% +83.4% — 13.9%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Short & Settlement
Short Volume
Short vol %
100%
As of
Aug 21, 2026
Short Total
View
Fails to Deliver
FTD shares
1
Value
$1
As of
Apr 26, 2023
View
Off-Exchange
Off-exchange %
100.0%
Week of
Aug 17, 2026
Off-exch Lit
View
Financials
Financials
Net income (FY)
$-13.4M
EPS diluted
$-0.22
View
Filings
SEC Filings
Latest
10-Q
Filed
Aug 13, 2026
This year
6
View

Performance

5D 20D 120D MTD YTD
RVRC +186.0% +5.9% — +0.0% +175.0%
SPY +0.1% -0.4% +15.1% +0.4% +12.9%
vs SPY +185.9% +6.3% — -0.4% +162.1%